Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
EQS-News: ​​​​​​​Eckert & Ziegler Plans Change of Legal Form to European Stock Corporation (SE)
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter
Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter


Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease

EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
EQS-News: Eckert & Ziegler with Unchanged Dividend Proposal
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of

David A. Jones Elected Chairman of the Humana Foundation Board of Directors
David A. Jones Elected Chairman of the Humana Foundation Board of Directors


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors

LivaNova to Announce First-Quarter 2023 Results
LivaNova to Announce First-Quarter 2023 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m

Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2023, the period ended February 28, 2023, after the close of the

Agilent Announced as Instrument Business Outlook 2022 Company of the Year
Agilent Announced as Instrument Business Outlook 2022 Company of the Year


Agilent Technologies Inc. (NYSE: A) announced today that it has been selected as Instrument Business Outlook (IBO) 2022 Company of the Year. IBO highlighted Agilent's increased growth in revenues

Humana Healthy Horizons Invests More Than $1 Million to Help Louisianans Overcome Health Challenges
Humana Healthy Horizons Invests More Than $1 Million to Help Louisianans Overcome Health Challenges


Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), announced today that it has contributed more than $1 million to non-profit

Simulations Plus to Present at Sidoti March Small-Cap Conference
Simulations Plus to Present at Sidoti March Small-Cap Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn

Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List
Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List


Waters Corporation’s (NYSE:WAT) companywide commitment to “leaving the world better than we found it” has earned it the number five ranking on the Barron’s 2023 100 Most Sustainable Companies U.S

Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it entered into a

Premier, Inc. Named One of the 2023 World’s Most Ethical Companies® by Ethisphere® for 16th Consecutive Year
Premier, Inc. Named One of the 2023 World’s Most Ethical Companies® by Ethisphere® for 16th Consecutive Year


Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been recognized by Ethisphere®, a global leader in defining and advancing the standards of ethical

DexCom Comments on SVB Relationship
DexCom Comments on SVB Relationship


DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:



“Dexcom does not

DexCom Comments on SVB Relationship
DexCom Comments on SVB Relationship


DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:



“Dexcom does not

Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023:
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023


Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia®

Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023


Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from Agilent, Visiopharm, Proscia®

Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu


Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range

Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu


Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range

Agilent Again Named One of Barron’s 100 Most Sustainable Companies: https://unsplash.com/photos/WUehAgqO5hE
Agilent Again Named One of Barron’s 100 Most Sustainable Companies


For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron’s list of America’s 100 Most Sustainable Companies.



The ranking is based on the performance of

Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development:
Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development


Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell.

LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova to Present at the Barclays Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Barclays

Humana’s Economic Impact in Florida Totals $48 Billion
Humana’s Economic Impact in Florida Totals $48 Billion


An independent economic research analysis estimated that leading health and well-being company Humana Inc. (NYSE: HUM) would contribute a total of $48 billion in overall economic impact in the